Home

Glaxo Wellcome:

23 July 1999

Operating from 76 different countries, the company’s extensive drug portfolio includes the ulcer blockbuster Zantac and the asthma inhaler Ventolin. Glaxo Wellcome is about to launch two new products: Ziagen, a new anti-HIV treatment, and its latest asthma drug, Flixotide.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Try Property Week For Free to finish this article.

Sign up now for the following benefits:

  • Unlimited access to Property Week
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article TRY FOR FREE NOW

Don’t want full access? REGISTER NOW to read this article and up to 3 more this month and subscribe to our newsletters.

Registered users and subscribers SIGN IN here to continue